NeoGenomics Q3 revenue up 10% to $168M; adjusted EBITDA up 305%, raises FY guidance to $37-40M

NEOGENOMICS INC

Consolidated revenue $168M (+10% YoY); Clinical Services revenue $146M (+14%) with test volume +9%.
Net loss decreased 4% to $18M; adjusted EBITDA improved 305% to $13M, fifth consecutive positive quarter.
FY 2024 adjusted EBITDA guidance raised to $37-40M (from $33-37M); revenue guidance unchanged at $655-667M.
Board appointed Felicia Williams; initial equity award ~$140,000 vesting June 1, 2025.

item 2.02 item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Felicia Williams

member of the Board

NEO · NEOGENOMICS INC

Effective: 2024-11-01
Filed: November 5, 2024, 6:59 PM ET

On November 1, 2024, the Board of Directors of the Company, appointed Felicia Williams to serve as a member of the Board, the Company’s Audit and Finance Committee (the “Audit Committee”) and the Company’s Nominating and Corporate Governance Committee (the “NCG Committee”).

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Felicia Williams was appointed as member of the Board at NEOGENOMICS INC.

Action: appointed
Role: member of the Board

Exact text from the filing

On November 1, 2024, the Board of Directors of the Company, appointed Felicia Williams to serve as a member of the Board, the Company’s Audit and Finance Committee (the “Audit Committee”) and the Company’s Nominating and Corporate Governance Committee (the “NCG Committee”).

View on SEC.gov

NEOGENOMICS INC filing history →

Source: SEC EDGAR

accession 0001077183-24-000153

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.